B cell development: Signal transduction by antigen receptors and their surrogates

Current Opinion in Immunology

Volumn 11, Issue 2, 1999, Pages 143-151

  Benschop, Robert J ^a   Cambier, John C ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOCYTE RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CLONAL ANERGY; HUMAN; MOUSE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033118746     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80025-9     Document Type: Article

References (87)

1. -/- mice induced progression to the pre-B cell stage. Signaling through CD79a-CD79b is thus concluded to be essential for transition from late pro-B cells into pre-B cells.
2. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K: A critical role of lambda 5 protein in B cell development. Cell 1992, 69:823-831.
3. Kitamura D, Rajewsky K: Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 1992, 356:154-156.
4. -/- mice were analyzed for their heavy-chain rearrangement status. In both mice, a small proportion of cells (3-7%) was found to have both heavy chain alleles rearranged; one of these alleles encoded a μH chain that could form a pre-BCR while the other μH could not. These findings imply that allelic exclusion is induced by a pre-BCR signal, but does not require λ5.
5. Carsetti R, Kohler G, Lamers MC: Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995, 181:2129-2140.
6. Havran WL, DiGiusto DL, Gambier JC: mIgM:mIgD ratios on B cells: Mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells. J Immunol 1984, 132:1712-1716.
7. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
8. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
9. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426.
10. Ehlich A, Schaal S, Gu H, Kitamura D, Muller W, Rajewsky K: Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development. Cell 1993, 72:695-704.
11. Cronin FE, Jiang M, Abbas AK, Grupp SA: Role of mu heavy chain in B cell development. I. Blocked B cell maturation but complete allelic exclusion in the absence of Ig alpha/beta. J Immunol 1998, 161:252-259. This paper reports the effects on B cell development and allelic exclusion of an immunoglobulin-transgene specific for phosphorylcholine, in which the ability of the μ heavy chain to associate with CD79a-CD79b is compromised (by a YS→VV mutation). B cell development is blocked at the pre-B cell stage, while allelic exclusion is maintained. This demonstrates that CD79a-CD79b-mediated signaling is required for B cell development to pre-B and immature B cells and suggests that allelic exclusion may be induced via a different pathway.
12. + cells exhibit no um rearrangements but pre-B cells do contain light-chain rearrangements. LMP2A thus mimics signals that are normally mediated through the CD79a-CD79b-calnexin complex and the pre-BCR. Rearrangement of μm does not occur because LMP2A is expressed before the pre-BCR is assembled and provides an alternative signal.
13. Tiegs SL, Russell DM, Nemazee D: Receptor editing in self-reactive bone marrow B cells. J Exp Med 1993, 177:1009-1020.
14. Retter MW, Nemazee D: Receptor editing occurs frequently during normal B cell development. J Exp Med 1998, 188:1231-1238.
15. high cells died through apoptosis. Similar responses were induced by a calcium ionophore, ionomycin, suggesting that cells respond differently to BCR-mediated increases in intracellular calcium changes as a function of development.
16. Santulli-Marotto S, Retter MW, Gee R, Mamula MJ, Clarke SH: Autoreactive B cell regulation: Peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 1998, 8:209-219. An experimental model for peripheral tolerance is presented. Mice transgenic only for the immunoglobulin heavy chain were generated and pairing with the endogenous light chains led either to B cells which were specific for Sm or single-strand DNA or to non-autoreactive B cells. Autoreactive B cells are eliminated at the level of the transitional B cell. The authors propose that this late tolerance induction is due to a combination of low affinity BCRs and low antigen concentration and that elimination occurs as a result of increased mIgM expression by transitional B cells.
17. Cambier JC, Kettman JR, Vitetta ES, Uhr JW: Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J Exp Med 1976, 144:293-297.
18. Metcalf ES, Klinman NR: In vitro tolerance induction of neonatal murine B cells. J Exp Med 1976, 143:1327-1340.
19. Tamir I, Cambier JC: Antigen receptor signaling: Integration of protein tyrosine kinase functions. Oncogene 1998, 17:1353-1364.
20. DeFranco AL: The complexity of signaling pathways activated by the BCR. Curr Opin Immunol 1997, 9:296-308.
21. Fu C, Turck CW, Kurosaki T, Chan AC: BLNK: A central linker protein in B cell activation. Immunity 1998, 9:93-103. See annotation to [22•].
22. Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M: SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998, 188:791-795. In [21••,22•], a novel B-cell-specific linker molecule (BLNK or SLP-65) and its role in BCR-mediated signaling are described. SLP-65 shows homology to SLP-76 which serves as an important linker molecule in T cells. In B cells, SLP-65 is rapidly tyrosyl-phosphorylated by Syk upon BCR aggregation - providing SH2-dependenl binding of PLCγ, Vav, Grb2 and Nck. The central role of SLP-65 in BCR-mediated signaling is illustrated by its positive effect on downstream calcium mobilization.
23. Kolanus W, Romeo C, Seed B: T cell activation by clustered tyrosine kinases. Cell 1993, 74:171-183.
24. Kurosaki T, Johnson SA, Pao L, Sada K, Yamamura H, Cambier JC: Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J Exp Med 1995, 182:1815-1823.
25. Buhl AM, Pleiman CM, Rickert RC, Cambier JC: Qualitative regulation of B cell antigen receptor signaling by CD19: Selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med 1997, 186:1897-1910. See annotation [28•].
26. Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ: Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J 1998, 17:1973-1985. See annotation [28•].
27. Bolland S, Pearse RN, Kurosaki T, Ravetch JV: SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998, 8:509-516. See annotation [28•].
28. 3 thus inhibiting continued presence of Btk and PLCγ at the plasma membrane.
29. Jiang A, Craxton A, Kurosaki T, Clark EA: Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J Exp Med 1998, 188:1297-1306. See annotation [30•].
30. Hashimoto A, Okada H, Jiang A, Kurosaki M, Greenberg S, Clark EA, Kurosaki T: Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med 1998, 188:1287-1295. In [29•,30•], the role of signaling intermediaries in BCR-mediated activation of MAPK family members p38, JNK and ERK are investigated in the chicken lymphoma model DT40. ERK activation depends on Ras, PLCγ and Syk but not on Lyn or Shc; JNK activation depends on Syk, Btk, Ras and PLCγ but not on Lyn; p38 activation depends on Ras and PLCγ but is intact in Lyn-, Btk- or Syk-deficient DT40 cells while the absence of both Lyn and Syk inhibits p38 activation. Together, the data demonstrate that, at least in this model, BCR-mediated MAPK activation crucially depends on PLCγ and Ras while activation is differentially regulated at the level of protein tyrosine kinases.
31. Rickert RC, Rajewsky K, Roes J: Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995, 376:352-355.
32. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF: Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995, 3:39-50.
33. Kishihara K, Penninger J, Wallace VA, Kundig TM, Kawai K, Wakeham A, Timms E, Pfeffer K, Ohashi PS, Thomas ML et al.: Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 1993, 74:143-156.
34. Maecker HT, Levy S: Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 1997, 185:1505-1510.
35. Lam KP, Kuhn R, Rajewsky K: In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90:1073-1083. This is an important contribution, investigating the role of BCR expression in mature B cells using inducible-gene-targeting techniques. Ablation of BCR expression led to rapid cell death, preceded by downregulation of MHC class II and upregulation of CD95 (Fas). Cell death is delayed by constitutive bcl-2 expression, supporting the notion that cells die by apoptosis. Together the data indicate that continued B cell survival in the periphery actively depends on BCR expression.
36. Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA: CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996, 384:634-637.
37. Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC: CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 1997, 7:133-143.
38. O'Keefe TL, Williams GT, Davies SL, Neuberger MS: Hyperresponsive B cells in CD22-deficient mice. Science 1996, 274:798-801.
39. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF: CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice. Immunity 1996, 5:551-562.
40. Campbell KS, Cambier JC: B lymphocyte antigen receptors (mIg) are non-covalently associated with a disulfide linked, inducibly phosphorylated glycoprotein complex. EMBO J 1990, 9:441-448.
41. Campbell KS, Bedzyk WD, Cambier JC: Manipulation of B cell antigen receptor tyrosine phosphorylation using aluminum fluoride and sodium orthovanadate. Mol Immunol 1995, 32:1283-1294.
42. Shaffer AL, Schlissel MS: A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development. J Immunol 1997, 159:1265-1275.
43. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC: Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 1996, 381:325-328.
44. + B cells in the spleen. High levels of autoantibodies were detected in the serum, indicating a breakdown in tolerance. These data demonstrate the importance of the level of CD19 in B cell selection and biologic responsiveness.
45. Sanchez M, Misulovin Z, Burkhardt AL, Mahajan S, Costa T, Franke R, Bolen JB, Nussenzweig M: Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med 1993, 178:1049-1055.
46. Papavasiliou F, Misulovin Z, Suh H, Nussenzweig MC: The role of Ig beta in precursor B cell transition and allelic exclusion. Science 1995, 268:408-411.
47. Papavasiliou F, Jankovic M, Suh H, Nussenzweig MC: The cytoplasmic domains of immunoglobulin (Ig) alpha and Ig beta can independently induce the precursor B cell transition and allelic exclusion. J Exp Med 1995, 182:1389-1394.
48. Pao LI, Famiglietti SJ, Cambier JC: Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction. J Immunol 1998, 160:3305-3314.
49. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M: Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994, 79:901-912.
50. Gong S, Nussenzweig MC: Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 1996, 272:411-414.
51. Nutt SL, Urbanek P, Rolink A, Busslinger M: Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 1997, 11:476-491.
52. Fitzsimmons D, Hodsdon W, Wheat W, Maira SM, Wasylyk B, Hagman J: Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev 1996, 10:2198-2211.
53. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M: Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 1998, 17:2319-2333. This is an important contribution - demonstrating that BSAP functions as a transactivator, repressor or docking protein in regulating the expression of genes early in B cell development. BSAP positively regulates the expression of CD79a and the transcription factors N-myc and LEF-1, while the expression of PD-1 (the product of a lymphocyte-specific early response gene) is negatively regulated. These findings help to define regulatory steps in early B cell development.
54. Torres RM, Flaswinkel H, Reth M, Rajewsky K: Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 1996, 272:1804-1808.
55. Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL: Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995, 378:298-302.
56. Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T: Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995, 378:303-306.
57. -/- cells, this does not overcome the maturational block. The results suggest that Syk transduces a BCR signal that is absolutely required for positive selection of immature B cells into the recirculating mature B cell compartment.
58. -/- background. Neither construct was able to induce developmental progression despite membrane expression of a pre-BCR. Since the pre-BCR seems unable to transmit signals, the data suggest a requirement for additional Pax5-dependent factors for progression from the pro- to the pre-B cell stage.
59. - stage and DJ, and some clonal VDJ, rearrangements are observed. Clonal expansion occurs after DJ rearrangements and before VDJ rearrangement. Blk probably participates in the proliferative expansion of late pro-B cells to large pre-B cells. This function seems to be redundant normally, based on the authors' unpublished observations that B cell development is unaffected in Blk-knockout, Blk-inactive-transgenic or SH2-deficient-Blk mice.
60. Appleby MW, Kerner JD, Chien S, Maliszewski CR, Bondada S, Perlmutter RM, Bondadaa S: Involvement of p59fynT in interleukin-5 receptor signaling. J Exp Med 1995, 182:811-820.
61. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR: Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995, 83:301-311.
62. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T: Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 1995, 3:549-560.
63. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA: Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 1997, 7:69-81.
64. Sillman AL, Monroe JG: Surface IgM-stimulated proliferation, inositol phospholipid hydrolysis, Ca2+ flux, and tyrosine phosphorylation are not altered in B cells from p59fyn-1- mice. J Leukoc Biol 1994, 56:812-816.
65. Chan VW, Lowell CA, DeFranco AL: Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr Biol 1998, 8:545-553. See annotation [67•].
66. Smith KGC, Tarlinton DM, Doody GM, Hibbs ML, Fearon DT: Inhibition of the B cell by CD22: A requirement for Lyn. J Exp Med 1998, 187:807-811. See annotation [67•].
67. Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC: Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 1998, 8:497-508. These papers [65•-67•] describe the requirement for Lyn in negative regulation of BCR-mediated signaling. Using animals deficient for Lyn, CD22 and/or SHP-1 it was demonstrated that CD22 is the target for Lyn. In the absence of tyrosyl phosphorylation, CD22 does not recruit SHP-1 - which is necessary for the negative regulation of calcium mobilization. In addition, all three molecules appear to be limiting in this negative regulatory pathway.
68. ras and Raf are therefore implicated in the signaling pathways early in development and are involved in the transition from pro-B cells to pre-B cells.
69. Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON: Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways. J Exp Med 1998, 188:833-844.
70. Takeshita H, Taniuchi I, Kato J, Watanabe T: Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene. Int Immunol 1998, 10:435-444.
71. high) B cells are virtually absent while the pro-B cell, pre-B cell and immature B cell compartments are normal. While serum immunoglobulin levels were essentially normal, T-cell-dependent and -independent responses were severely impaired. Mice exhibit disrupted splenic architecture and the authors conclude that Btk is important for generating mature recirculating follicular B cells.
72. Mizuno K, Katagiri T, Hasegawa K, Ogimoto M, Yakura H: Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells. J Exp Med 1996, 184:457-463.
73. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT: CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav. Immunity 1998, 8:635-645.
74. Clements JL, Ross-Barta SE, Tygrett LT, Waldschmidt TJ, Koretzky GA: SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activation. J Immunol 1998, 161:3880-3889. See annotation to [78•].
75. Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL: Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995, 374:467-470.
76. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 1995, 374:470-473.
77. Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS: Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 1998, 94:229-238. See annotation [78•].
78. Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA: Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 1998, 281:416-419. References [74•,77•,78•] demonstrate that SLP-76 is an hematopoietic-cell-specific adapter protein. As demonstrated, SLP-76 is expressed in T lymphocytes, macrophages and natural killer (NK) cells but is absent in B lymphocytes. Genetic ablation of SLP-76 leads to an early block in T cell development and there are no mature T cells present. Despite expression in normal NK cells and macrophages, these compartments are intact in knockout mice and - in line with the expression pattern - no B cell abnormalities were observed. Thus SLP-76 is crucial in mediating TCR signals early in development.
79. Wechsler RJ, Monroe JG: Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr1. J Immunol 1995, 154:1919-1929.
80. Yellen AJ, Glenn W, Sukhatme VP, Cao XM, Monroe JG: Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice. J Immunol 1991, 146:1446-1454.
81. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI: Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997, 386:855-858. See annotation [82••].
82. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC: Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997, 6:419-428. These papers [81••,82••] link differences in calcium responses to distinct downstream transcription regulators. NF-κB and JNK are selectively activated by a large, transient rise in intracellular calcium whereas NFAT is activated by a low, sustained calcium plateau; furthermore, BCR-mediated signaling in naive cells triggers a large biphasic calcium response whereas low calcium oscillations are observed in tolerant B cells. Together these data reveal a mechanism by which a multifunctional second messenger, such as calcium, can achieve specificity in signaling to the nucleus and demonstrate the biologic significance of these events in naive and tolerant B cells.
83. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991, 173:1213-1225.
84. Osmond DG, Rolink A, Melchers F: Murine B lymphopoiesis: Towards a unified model. Immunol Today 1998, 19:65-68.
85. Rolink A, Grawunder U, Winkler TH, Karasuyama H, Melchers F: IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol 1994, 6:1257-1264.
86. b (thus excluding association with endogenous CD79a-CD79b) and the cytoplasmic tails of CD79a or CD79b. Expression of these chimeras restored both B cell development to mature B cells and allelic exclusion as well as allowing for B cell activation. Although expression of both chimeras induces optimal activity, the individual CD79a or CD79b chimeras were sufficient to mediate many of the essential functions of the BCR.
87. Papavasiliou F, Jankovic M, Nussenzweig MC: Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition. J Exp Med 1996, 184:2025-2030.